In reply to an article published in your journal Cancer Letters, 128 (1998) 87-92, by V.N. Bilim et al.
Gazzaniga
P
P
Aglianó
A M
AM
D002295:Carcinoma, Transitional Cell / Q000378:metabolism*; D015870:Gene Expression; D006801:Humans; D011518:Proto-Oncogene Proteins / Q000235:genetics* / Q000378:metabolism; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000235:genetics* / Q000378:metabolism; D012333:RNA, Messenger / Q000096:biosynthesis; D001749:Urinary Bladder Neoplasms / Q000378:metabolism*; D051028:bcl-2-Associated X Protein; D051020:bcl-X Protein
C494811:BCL2L1 protein, human; D011518:Proto-Oncogene Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D012333:RNA, Messenger; D051028:bcl-2-Associated X Protein; D051020:bcl-X Protein